BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2831923)

  • 1. In vivo magnetic resonance imaging and 31P spectroscopy of large human brain tumours at 1.5 tesla.
    Thomsen C; Jensen KE; Achten E; Henriksen O
    Acta Radiol; 1988; 29(1):77-82. PubMed ID: 2831923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Image-guided localized 31P NMR spectroscopy of the human brain at 1.5T].
    Heindel W; Bunke J; Steinbrich W
    Rofo; 1987 Oct; 147(4):374-8. PubMed ID: 2825257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [MR imaging of intracranial tumors by superconducting system operating at 0.35 tesla].
    Ochiai C
    No To Shinkei; 1985 May; 37(5):445-57. PubMed ID: 2992555
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of in vivo proton MR spectroscopy in the evaluation of adult brain lesions: our preliminary experience.
    Kumar A; Kaushik S; Tripathi RP; Kaur P; Khushu S
    Neurol India; 2003 Dec; 51(4):474-8. PubMed ID: 14742925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adult primitive neuroectodermal tumor: proton MR spectroscopic findings with possible application for differential diagnosis.
    Majós C; Alonso J; Aguilera C; Serrallonga M; Acebes JJ; Arús C; Gili J
    Radiology; 2002 Nov; 225(2):556-66. PubMed ID: 12409595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo 1H spectroscopy of the human brain at 1.5 tesla. Preliminary experience at a clinical installation.
    Henriksen O; Larsson H; Jensen KM
    Acta Radiol; 1990 Mar; 31(2):181-6. PubMed ID: 2372461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of proton MRS in the differential diagnosis of brain tumors and tumor-like processes.
    Gajewicz W; Papierz W; Szymczak W; Goraj B
    Med Sci Monit; 2003 Sep; 9(9):MT97-105. PubMed ID: 12960934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Application of (1)H MR spectroscopic imaging in radiation oncology: choline as a marker for determining the relative probability of tumor progression after radiation of glial brain tumors].
    Lichy MP; Bachert P; Hamprecht F; Weber MA; Debus J; Schulz-Ertner D; Schlemmer HP; Kauczor HU
    Rofo; 2006 Jun; 178(6):627-33. PubMed ID: 16703499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Very late frontal relapse of medulloblastoma mimicking a meningioma in an adult: usefulness of 1H magnetic resonance spectroscopy and diffusion-perfusion magnetic resonance imaging for preoperative diagnosis: case report.
    Jouanneau E; Guzman Tovar RA; Desuzinges C; Frappaz D; Louis-Tisserand G; Sunyach MP; Jouvet A; Sindou M
    Neurosurgery; 2006 Apr; 58(4):E789; discussion E789. PubMed ID: 16575298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton magnetic resonance spectroscopy of brain tumors correlated with pathology.
    Magalhaes A; Godfrey W; Shen Y; Hu J; Smith W
    Acad Radiol; 2005 Jan; 12(1):51-7. PubMed ID: 15691725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI.
    Fayed N; Dávila J; Medrano J; Olmos S
    Eur J Radiol; 2008 Sep; 67(3):427-33. PubMed ID: 18442889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MR imaging in cerebral gliomas. Tissue component analysis in correlation with histopathology of whole-brain specimens.
    Tovi M; Hartman M; Lilja A; Ericsson A
    Acta Radiol; 1994 Sep; 35(5):495-505. PubMed ID: 8086262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo hydrogen-1 magnetic resonance spectroscopy study of human intracranial tumors.
    Luan W; Zhang J
    Chin Med J (Engl); 1998 Jan; 111(1):56-8. PubMed ID: 10322655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Nuclear spin tomography in brain tumors. Evaluation of 40 confirmed cases].
    Uhlenbrock D; Beyer HK; Grote W
    Rofo; 1985 Nov; 143(5):501-7. PubMed ID: 2999887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vivo magnetic resonance spectroscopy].
    Bakken IJ; Skjetne T; Gribbestad IS; Kvistad KA
    Tidsskr Nor Laegeforen; 2002 May; 122(14):1365-8. PubMed ID: 12098905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance imaging of rare intracranial neoplasms--role of the in vivo 1 h spectroscopy in the radiological differential diagnostics.
    Fortuniak J; Jaskólski DJ; Stefańczyk L; Zawirski M; Gajewicz W
    Cent Eur Neurosurg; 2010 Nov; 71(4):181-8. PubMed ID: 21082514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of high-resolution magic angle spinning proton magnetic resonance spectroscopy with histopathology of intact human brain tumor specimens.
    Cheng LL; Chang IW; Louis DN; Gonzalez RG
    Cancer Res; 1998 May; 58(9):1825-32. PubMed ID: 9581820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo differentiation of astrocytic brain tumors and isolated demyelinating lesions of the type seen in multiple sclerosis using 1H magnetic resonance spectroscopic imaging.
    De Stefano N; Caramanos Z; Preul MC; Francis G; Antel JP; Arnold DL
    Ann Neurol; 1998 Aug; 44(2):273-8. PubMed ID: 9708554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro study of astrocytic tumour metabolism by proton magnetic resonance spectroscopy.
    Likavcanová K; Dobrota D; Liptaj T; Prónayová N; Mlynárik V; Belan V; Galanda M; Béres A; De Riggo J
    Gen Physiol Biophys; 2005 Sep; 24(3):327-35. PubMed ID: 16308427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single voxel proton MR spectroscopy findings of typical and atypical intracranial meningiomas.
    Demir MK; Iplikcioglu AC; Dincer A; Arslan M; Sav A
    Eur J Radiol; 2006 Oct; 60(1):48-55. PubMed ID: 16844335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.